Pacific Biosciences of California

Yahoo Finance • 8 days ago

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a s... Full story

Yahoo Finance • 27 days ago

PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow

MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined... Full story

Yahoo Finance • last month

PacBio (PACB) Stock Trades Up, Here Is Why

What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 8.3% in the afternoon session after Federal Reserve Chair Jerome Powell opened the door to potential interest rate cuts. The broader market... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • 2 months ago

Pacific Biosciences stock price target raised by Bernstein to $1.70 on clinical uptake

Investing.com - Bernstein SocGen Group raised its price target on Pacific Biosciences of California (NASDAQ:PACB) to $1.70 from $1.50 while maintaining an Outperform rating. The new target represents a 35% upside from the current price of... Full story

Yahoo Finance • 2 months ago

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming inves... Full story

Yahoo Finance • 2 months ago

Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models

MENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the results of a study published in NatureMethods describing a new, co... Full story

Yahoo Finance • 2 months ago

PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit forecast after reporting a significant surge in medical costs, sending shockwaves across the health... Full story

Yahoo Finance • 2 months ago

Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings

We recently published These 10 Stocks are Winning Big. Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the best-performing stocks on Monday. Pacific Biosciences jumped by 6.49 percent on Monday to close at $1.64 apiece as... Full story

Yahoo Finance • 2 months ago

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for global genomic equity. Researchers have... Full story

Yahoo Finance • 2 months ago

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which wi... Full story

Yahoo Finance • 2 months ago

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025

MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm East... Full story

Yahoo Finance • 3 months ago

Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue

Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NASDAQ:PACB) delivered a presentation at the 46th Annual G... Full story

Yahoo Finance • 4 months ago

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood t... Full story

Yahoo Finance • 5 months ago

First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

MENLO PARK, Calif. and BANGKOK, May 05, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) a leading provider of high-quality, highly accurate sequencing platforms, and Chulalongkorn University, a national leader in genomic and translational... Full story

Yahoo Finance • 5 months ago

Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa

MENLO PARK, Calif. and GENEVA, Switzerland , April 22, 2025 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC), a global initiative to prevent Alzheimer’s disease and improve brain health, today announced that PacBio (NASDAQ:... Full story

Yahoo Finance • 6 months ago

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today... Full story

Yahoo Finance • 6 months ago

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors g... Full story

Yahoo Finance • 6 months ago

Jim Gibson to join PacBio as Chief Financial Officer

MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Fin... Full story

Yahoo Finance • 6 months ago

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful... Full story